NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- JuicyChat.AI has launched its next-generation NSFW AI Role Play Chatbot, ...

OroBit positions Bitcoin to unlock those trillions by revolutionizing how real-world assets—previously constrained by ...

EDMONTON, Alberta, March 28, 2025 (GLOBE NEWSWIRE) -- Capital Power Corporation (TSX: CPX) will release its 2025 first quarter results before the markets open on May 1, 2025. A conference call and ...

FORT MILL, S.C., March 28, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today ...

WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced ...

JAKKS Pacific, Inc. (NASDAQ: JAKK) today announced that the Board of Directors (the “Board”) approved the scheduling of the 2025 annual meeting for June 20, 2025, and also announced changes to the ...

Ferrari said the price hikes would apply to all models except the 296, SF90, and Roma, and to those imported after April 2.

Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor ...

Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an Ideal Third Drug to ...

Rocket Lab USA (RKLB) stock soared over 9% in pre-market trading on Friday after it made a bold entry into the U.S. Space Force’s National ...

Sensei Biotherapeutics (SNSE) announced initial results from the dose expansion portion of its Phase 1/2 trial evaluating solnerstotug, a ...

The stock of AppLovin (APP) is down 20% as a third short seller raises concerns about the company’s digital advertising ...